Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. SPY
4. MU
5. NVDA
6. BE
7. SPCX
8. STZ
9. META
10. ABVX

Go back to Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update

Vivos Therapeutics, Inc. (VVOS) Misses Q3 EPS by 1c

December 20, 2022 4:18 PM EST

Vivos Therapeutics, Inc. (NASDAQ: VVOS) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.72 million.

For earnings history and earnings-related data on Vivos Therapeutics, Inc. (VVOS) click here.

... More